These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3122268

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fluphenazine treatment of DSM-III-R male schizophrenic patients among the Xhosa.
    Landmark J, Merskey H, Cernovsky ZZ.
    Can J Psychiatry; 1994 May; 39(4):219-22. PubMed ID: 8044729
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G, Annable L, Campbell W.
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [Abstract] [Full Text] [Related]

  • 7. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS, Yeo SH.
    Pharmatherapeutica; 1989 Aug; 5(6):371-9. PubMed ID: 2687894
    [Abstract] [Full Text] [Related]

  • 8. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA.
    Pharmatherapeutica; 1983 Aug; 3(5):289-93. PubMed ID: 6133287
    [Abstract] [Full Text] [Related]

  • 9. Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate.
    Marder SR, Aravagiri M, Wirshing WC, Wirshing DA, Lebell M, Mintz J.
    Schizophr Res; 2002 Jan 01; 53(1-2):25-30. PubMed ID: 11728835
    [Abstract] [Full Text] [Related]

  • 10. Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
    Kelly HB, Freeman HL, Banning B, Schiff AA.
    Int Pharmacopsychiatry; 1977 Jan 01; 12(1):54-64. PubMed ID: 406212
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
    Odejide OA, Aderounmu AF.
    J Clin Psychiatry; 1982 May 01; 43(5):195-6. PubMed ID: 7076630
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A, Okasha MS, Salih MA, Hirsch SR.
    Br J Psychiatry; 1979 Dec 01; 135():515-23. PubMed ID: 394794
    [Abstract] [Full Text] [Related]

  • 16. Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophrenia.
    Chang SS, Javaid JI, Dysken MW, Casper RC, Janicak PG, Davis JM.
    Psychopharmacology (Berl); 1985 Dec 01; 87(1):55-8. PubMed ID: 3933037
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia.
    Leong OK, Wong KE, Tay WK, Gill RC.
    Singapore Med J; 1989 Oct 01; 30(5):436-40. PubMed ID: 2575796
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A double-blind comparison of fluspirilene and fluphenazine decanoate in schizophrenia.
    Russell N, Landmark J, Merskey H, Turpin T.
    Can J Psychiatry; 1982 Nov 01; 27(7):593-6. PubMed ID: 7172160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.